Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Henry Schein Inc (HSIC) COM STK NPV

Sell:$69.42 Buy:$69.45 Change: $0.25 (0.36%)
NASDAQ:1.00%
Market closed |  Prices as at close on 6 December 2019 | Switch to live prices |
Sell:$69.42
Buy:$69.45
Change: $0.25 (0.36%)
Market closed |  Prices as at close on 6 December 2019 | Switch to live prices |
Sell:$69.42
Buy:$69.45
Change: $0.25 (0.36%)
Market closed |  Prices as at close on 6 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The Company provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.

Contact details

Address:
135 Duryea Rd
MELVILLE
11747
United States
Telephone:
+1 (631) 8435500
Website:
https://www.henryschein.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HSIC
ISIN:
US8064071025
Market cap:
$10.15 billion
Shares in issue:
146.74 million
Sector:
Health Care Distributors
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Stanley Bergman
    Chairman of the Board, Chief Executive Officer
  • James Breslawski
    President, Vice Chairman of the Board, Director
  • Steven Paladino
    Chief Financial Officer, Executive Vice President, Director
  • Brad Connett
    President - Henry Schein'sU.S. Medical Group
  • David McKinley
    President of Corporate Commercial Development Group, Chief Commercial Officer
  • Gerald Benjamin
    Chief Administrative Officer, Executive Vice President, Director
  • Mark Mlotek
    Chief Strategic Officer, Executive Vice President, Director
  • Christopher Pendergast
    Senior Vice President, Chief Technology Officer
  • Walter Siegel
    Senior Vice President, General Counsel
  • Lorelei McGlynn
    Senior Vice President - Global Human Resources and Financial Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.